Download presentation
Presentation is loading. Please wait.
Published byΚλεοπάτρα Οικονόμου Modified over 6 years ago
1
Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease Marc Bosiers, MD, Dierk Scheinert, MD, Patrick Peeters, MD, Giovanni Torsello, MD, Thomas Zeller, MD, Koen Deloose, MD, Andrej Schmidt, MD, Jörg Tessarek, MD, Erwin Vinck, Lewis B. Schwartz, MD Journal of Vascular Surgery Volume 55, Issue 2, Pages (February 2012) DOI: /j.jvs Copyright © 2012 Society for Vascular Surgery Terms and Conditions
2
Fig 1 Primary patency of infrapopliteal lesions treated in the DESTINY trial. The difference in patency between the Vision and Xience V groups was highly statistically significant (P = .001). Journal of Vascular Surgery , DOI: ( /j.jvs ) Copyright © 2012 Society for Vascular Surgery Terms and Conditions
3
Fig 2 Freedom from target lesion revascularization (TLR) of infrapopliteal lesions treated in the DESTINY trial. The difference in TLR between the Vision and Xience V groups was highly statistically significant (P = .001). Journal of Vascular Surgery , DOI: ( /j.jvs ) Copyright © 2012 Society for Vascular Surgery Terms and Conditions
4
Fig 3 Clinical outcome of patients treated in the DESTINY trial by Rutherford class. The top panel represents the Vision group and the bottom panel represents the Xience V group. Journal of Vascular Surgery , DOI: ( /j.jvs ) Copyright © 2012 Society for Vascular Surgery Terms and Conditions
5
Fig 4 Survival of patients treated in the DESTINY trial. There was no observed difference in survival between the Vision and Xience V groups (P = .96). Journal of Vascular Surgery , DOI: ( /j.jvs ) Copyright © 2012 Society for Vascular Surgery Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.